DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Kyle Rasbach will serve on a panel at the World Orphan Drug Congress USA 2020
Event | 08. 27. 2020
Kyle Rasbach will serve on the panel “Evaluating investment opportunities in the rare disease & orphan space” at the World Orphan Drug Congress USA 2020.
